ABIO To Report Data In Q1; IOVA Fired Up, PMD In Iowa, VRX All Cleared

Today's Daily Dose brings you news about Acadia Healthcare's secondary offering; ARCA's progress in GENETIC-AF trial; Iovance's milestone that has boosted investor optimism; Psychemedics' role to play testing of drugs of abuse; Seattle Genetics' upcoming regulatory catalyst and inspection classification of Valeant's Bausch + Lomb manufacturing facility in Tampa, Florida.

from RTT - Biotech http://ift.tt/2x6ofS4
via IFTTT